Accentia Biopharmace (ABPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABPI | AZN | AMGN | GILD | VRTX |
| Company | Accentia Biopharmace | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0001 | 94.14 | 327.42 | 122.59 | 460.22 |
| High | 0.0001 | 94.54 | 327.75 | 123.81 | 462.42 |
| Low | 0.0001 | 92.78 | 319.79 | 120.22 | 452.91 |
| Latest | 0.0001 | 94.51 | 324.30 | 121.76 | 454.67 |
| Change | unch | +0.88 | -1.24 | -0.84 | -5.92 |
| % Change | unch | +0.94% | -0.38% | -0.69% | -1.29% |
| Volume | 400 | 8,037,200 | 2,382,200 | 5,803,800 | 1,346,100 |
| 20-Day Average Volume | 25,130 | 5,142,935 | 2,783,475 | 6,416,970 | 1,351,250 |
| Previous Close | 0.0001 | 93.63 | 325.54 | 122.60 | 460.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0001 | 92.52 | 328.57 | 122.40 | 458.92 |
| 20-Day Raw Stochastic | 0.00% | 71.35% | 24.52% | 46.34% | 26.01% |
| 20-Day Relative Strength | 34.07 | 60.50 | 48.91 | 49.21 | 52.22 |
| Weighted Alpha | -45.13 | +44.67 | +18.96 | +27.64 | +8.62 |
| Today's Opinion | N/A | 100% Buy | 48% Buy | 40% Buy | 64% Buy |
| Previous Opinion | N/A | 100% Buy | 64% Buy | 56% Buy | 88% Buy |
| Last Month's Opinion | N/A | 88% Buy | 72% Buy | 72% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 12/30/15 | -0.47% since 01/06/26 | -1.78% since 01/06/26 | +0.33% since 01/06/26 | -2.93% since 01/06/26 |
| Low | 0.0001 on 01/06/16 | 92.78 on 01/13/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 452.91 on 01/13/26 |
| High | 0.0001 on 01/06/16 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 125.11 on 01/08/26 | 487.52 on 01/07/26 |
| 1-Month | |||||
| %Chg | unch since 11/24/15 | +5.21% since 12/12/25 | +2.06% since 12/12/25 | +1.13% since 12/12/25 | +0.58% since 12/12/25 |
| Low | 0.0001 on 01/06/16 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 443.12 on 01/05/26 |
| High | 0.0010 on 12/16/15 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | -97.22% since 10/05/15 | +11.83% since 10/13/25 | +10.91% since 10/13/25 | +3.00% since 10/13/25 | +11.61% since 10/13/25 |
| Low | 0.0001 on 01/06/16 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 0.0050 on 11/02/15 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | -97.96% since 07/06/15 | +32.87% since 07/11/25 | +9.83% since 07/11/25 | +11.05% since 07/11/25 | -3.02% since 07/11/25 |
| Low | 0.0001 on 01/06/16 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 0.0057 on 07/13/15 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 10 | 290,388,928 | 175,297,120 | 152,107,376 | 116,860,432 |
| Shares Outstanding, K | 89,760 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 4,050,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -4,320,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | N/A | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | N/A | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | -0.47 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 12/31/69 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.71 | 14.91 | 14.79 | 30.30 |